Age as a prognostic factor in the malignant melanoma population |
| |
| Authors: | Paul F Austin MD C Wayne Cruse MD Gary Lyman MD MPH Kenneth Schroer MD Frank Glass MD Dr Douglas S Reintgen MD |
| |
| Institution: | (1) From the Division of Surgical Oncology, University of South Florida Medical School, Tampa, Florida, USA;(2) Division of Plastic Surgery, University of South Florida Medical School, Tampa, Florida, USA;(3) Department of General Surgery, University of South Florida Medical School, Tampa, Florida, USA;(4) Division of Medical Oncology, University of South Florida Medical School, Tampa, Florida, USA;(5) Division Dermatology, University of South Florida Medical School, Tampa, Florida, USA;(6) Department of Medicine, University of South Florida Medical School, Tampa, Florida, USA;(7) Department of Pathology and Laboratory Medicine, University of South Florida Medical School, Tampa, Florida, USA;(8) Cutaneous Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Medical School, Tampa, Florida, USA;(9) Moffitt Cancer Center, University of South Florida, P.O. Box 280179, 33682-0179 Tampa, FL, USA |
| |
| Abstract: | Background: The incidence of malignant melanoma is increasing faster than any other cancer, and the state of Florida has one of the highest incidence of melanoma in the United States. This increased incidence is thought to be due to the intense sunlight exposure and ultraviolet radiation exposure in the elderly population. With the increased emphasis on issues of aging, it is appropriate to study the role of age as a prognostic factor for malignant melanoma in the Florida population.
Methods: A retrospective, computer-aided search identified 442 consecutively registered patients with malignant melanoma at the Cutaneous Oncology Program. All patients had stage 1 or 2 disease (cutaneous disease only) at diagnosis. Prognostic variables analyzed included the most powerful factors for stage 1 and 2 melanoma, tumor thickness, ulceration, and Clark level of invasion. Other prognostic variables included in the analysis were the clinical variables of sex and primary site (axial vs. extremity). The population was divided into patients  65 and >65 years of age.
Results: Significant disease-free survival differences were encountered in the older population, with only 55% of the elderly population being disease free at 5 years compared with 65% for the younger population (p=0.0073). However, a greater percentage of patients with melanoma who were >65 years of age had ulcerated lesions (17.5% vs. 12.9%) and a greater percentage of thick lesions at diagnosis (67.2% vs. 62.7%). Both of these prognostic factors would bias the older population with a poorer survival. A stepwise regression analysis of the entire population was performed, treating age as a continuous variable. Surprisingly, increasing age along with tumor thickness were the only significant predictors for disease-free survival. After inclusion of these two prognostic variables, none of the other prognostic factors, including Clark level, ulceration, sex, and primary site, added to the prognostic model.
Conclusions: From this analysis, it is apparent that geriatric patients with melanoma have a worse prognosis than a younger control population, even after the correction for the more commonly cited prognostic factors. This information should be used in mathematical modeling to identify high-risk populations who are candidates for perhaps more aggressive primary or adjuvant therapies.Presented at the 46th Annual Cancer Symposium of The Society of Surgical Oncology, Los Angeles, California, March 18–21, 1993. |
| |
| Keywords: | Age Melanoma Prognosis |
| 本文献已被 SpringerLink 等数据库收录！ |
|
